5432332026-01-012026-03-315432332026-03-315432332025-03-315432332025-04-012026-03-315432332026-01-012026-03-31in-capmkt:OtherExpenses1Member5432332025-04-012026-03-31in-capmkt:OtherExpenses1Member5432332026-03-31OtherNoncurrentFinancialAssetsDomain15432332026-03-31OtherNoncurrentAssetsDomain15432332026-03-31OtherNoncurrentAssetsDomain25432332026-03-31OtherCurrentFinancialAssetsDomain15432332026-03-31OtherCurrentAssetsDomain15432332026-03-31OtherCurrentFinancialLiabilitiesDomain15432332026-03-31OtherCurrentLiabilitiesDomain15432332026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432332025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432332026-01-012026-03-31RelatedPartyTransactionDomain15432332025-12-31RelatedPartyTransactionDomain15432332026-03-31RelatedPartyTransactionDomain15432332026-01-012026-03-31RelatedPartyTransactionDomain25432332025-12-31RelatedPartyTransactionDomain25432332026-03-31RelatedPartyTransactionDomain25432332026-01-012026-03-31RelatedPartyTransactionDomain35432332025-12-31RelatedPartyTransactionDomain35432332026-03-31RelatedPartyTransactionDomain35432332026-01-012026-03-31RelatedPartyTransactionDomain45432332025-12-31RelatedPartyTransactionDomain45432332026-03-31RelatedPartyTransactionDomain45432332026-01-012026-03-31RelatedPartyTransactionDomain55432332025-12-31RelatedPartyTransactionDomain55432332026-03-31RelatedPartyTransactionDomain55432332026-01-012026-03-31RelatedPartyTransactionDomain65432332025-12-31RelatedPartyTransactionDomain65432332026-03-31RelatedPartyTransactionDomain65432332026-01-012026-03-31RelatedPartyTransactionDomain75432332025-12-31RelatedPartyTransactionDomain75432332026-03-31RelatedPartyTransactionDomain75432332026-01-012026-03-31RelatedPartyTransactionDomain85432332025-12-31RelatedPartyTransactionDomain85432332026-03-31RelatedPartyTransactionDomain85432332026-01-012026-03-31RelatedPartyTransactionDomain95432332025-12-31RelatedPartyTransactionDomain95432332026-03-31RelatedPartyTransactionDomain95432332026-01-012026-03-31RelatedPartyTransactionDomain105432332025-12-31RelatedPartyTransactionDomain105432332026-03-31RelatedPartyTransactionDomain105432332026-01-012026-03-31RelatedPartyTransactionDomain115432332025-12-31RelatedPartyTransactionDomain115432332026-03-31RelatedPartyTransactionDomain115432332026-01-012026-03-31RelatedPartyTransactionDomain125432332025-12-31RelatedPartyTransactionDomain125432332026-03-31RelatedPartyTransactionDomain125432332026-01-012026-03-31RelatedPartyTransactionDomain135432332025-12-31RelatedPartyTransactionDomain135432332026-03-31RelatedPartyTransactionDomain135432332026-01-012026-03-31RelatedPartyTransactionDomain145432332025-12-31RelatedPartyTransactionDomain145432332026-03-31RelatedPartyTransactionDomain145432332026-01-012026-03-31RelatedPartyTransactionDomain155432332025-12-31RelatedPartyTransactionDomain155432332026-03-31RelatedPartyTransactionDomain155432332026-01-012026-03-31RelatedPartyTransactionDomain165432332025-12-31RelatedPartyTransactionDomain165432332026-03-31RelatedPartyTransactionDomain165432332026-01-012026-03-31RelatedPartyTransactionDomain175432332025-12-31RelatedPartyTransactionDomain175432332026-03-31RelatedPartyTransactionDomain175432332026-01-012026-03-31RelatedPartyTransactionDomain185432332025-12-31RelatedPartyTransactionDomain185432332026-03-31RelatedPartyTransactionDomain185432332026-01-012026-03-31RelatedPartyTransactionDomain195432332025-12-31RelatedPartyTransactionDomain195432332026-03-31RelatedPartyTransactionDomain195432332026-01-012026-03-31RelatedPartyTransactionDomain205432332025-12-31RelatedPartyTransactionDomain205432332026-03-31RelatedPartyTransactionDomain205432332026-01-012026-03-31RelatedPartyTransactionDomain215432332025-12-31RelatedPartyTransactionDomain215432332026-03-31RelatedPartyTransactionDomain215432332026-01-012026-03-31RelatedPartyTransactionDomain225432332025-12-31RelatedPartyTransactionDomain225432332026-03-31RelatedPartyTransactionDomain225432332026-01-012026-03-31RelatedPartyTransactionDomain235432332025-12-31RelatedPartyTransactionDomain235432332026-03-31RelatedPartyTransactionDomain235432332026-01-012026-03-31RelatedPartyTransactionDomain245432332025-12-31RelatedPartyTransactionDomain245432332026-03-31RelatedPartyTransactionDomain245432332026-01-012026-03-31RelatedPartyTransactionDomain255432332025-12-31RelatedPartyTransactionDomain255432332026-03-31RelatedPartyTransactionDomain255432332026-01-012026-03-31RelatedPartyTransactionDomain265432332025-12-31RelatedPartyTransactionDomain265432332026-03-31RelatedPartyTransactionDomain265432332026-01-012026-03-31RelatedPartyTransactionDomain275432332025-12-31RelatedPartyTransactionDomain275432332026-03-31RelatedPartyTransactionDomain275432332026-01-012026-03-31RelatedPartyTransactionDomain285432332025-12-31RelatedPartyTransactionDomain285432332026-03-31RelatedPartyTransactionDomain285432332026-01-012026-03-31RelatedPartyTransactionDomain295432332025-12-31RelatedPartyTransactionDomain295432332026-03-31RelatedPartyTransactionDomain295432332026-01-012026-03-31RelatedPartyTransactionDomain305432332025-12-31RelatedPartyTransactionDomain305432332026-03-31RelatedPartyTransactionDomain305432332026-01-012026-03-31RelatedPartyTransactionDomain315432332025-12-31RelatedPartyTransactionDomain315432332026-03-31RelatedPartyTransactionDomain315432332026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543233CHEMCONNOTLISTEDINE03YM01018Chemcon Speciality Chemicals LimitedMain BoardEquity2025-04-012026-03-312026-05-212026-05-15INRLakhsQuarterlyFourth quarterSingle segmentSpecialty Chemicals2026-05-2116:00:002026-05-2116:48:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-02-12https://cscpl.com/wp-content/uploads/investors-relations/policies/g-policy-on-dealing-with-related-party-transactions.pdffalsefalseThe disclosure for the default on loans and debt securities not applicable to the company.2026-01-012026-03-31AuditedStandalone754217000415550007957720005506630000-26637000530970001012100032390000882120007078460008792600008792600016770000744300024213000063713000000063713000411600067829000366307000101.741.74001.741.74Notes : <BR> <BR> 1 These Financial results have been prepared in accordance with the recognition and measurement principles of Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Companies Act, 2013 and read with the relevant rules issued thereunder and the other accounting principles generally accepted in India. <BR> <BR> 2 The above results have been reviewed by Audit Committee and the Board of Directors have approved the above results at their meeting held on May 21, 2026. The above results were audited by the Statutory Auditors. <BR> <BR> 3 The Company is in the business of manufacturing of Specialty Chemicals. There is only one reportable segment in accordance with Ind AS 108 - Operating Segments. <BR> <BR> 4 Figures of corresponding previous year/period(s) have been regrouped /rearranged wherever necessary, to make them comparable. <BR> 5 The Company has entered into a Slump Sale Agreement on October 18, 2025, for acquisition of the entire business undertaking of M/s. Shivam Petrochem Industries (Partnership Firm, a related party having business of Manufacturing of Speciality Chemicals) as a going concern for a lump sum consideration of Rs. 3600 Lakhs. The transaction was approved by the Board on August 5, 2025, and subsequently by the shareholders at the 36th Annual General Meeting held on September 11, 2025. <BR> <BR> 6 Effective 21 November 2025, the Government of India consolidated 29 existing labour regulations into four Labour Codes, collectively referred to as the “New Labour Codes”. Based on the requirements of the New Labour Codes and relevant Accounting Standards, the Company has assessed the potential impact on employee benefit obligations and determined that there is no material impact on the Statement of Profit and Loss for the quarter and year ended March 31, 2026. The Company will evaluate and account for any additional impact, if any, upon notification of the related Rules and further clarifications from the Government. <BR> 7 The Company has no subsidiary/ associate / Joint Venture Company , as on March 31, 2026. <BR> 8 The Board of Directors at its meeting held on May 21, 2026, have declared, an interim dividend of Rs. _______ per equity share of Rs. 10 each. <BR> 9 The figures of 3 months ended March 31, 2026 and corresponding 3 months ended on March 31, 2025 are the balancing figures between the audited figures in respect of full financial year and year to date figures up to the third quarter of the respective financial years. <BR> 10 The above Financial Results of the Company are available on the Company's website www.cscpl.com and also on the website of BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed.2025-04-012026-03-31AuditedStandalone23997890001545270002554316000145988900064637000343310002006300002112900011553200033858100022347290003195870000319587000763230007282000836050000235982000000023598200026010002385830003663070001044650950006.446.44006.446.44Other Expenses88212000Other Expenses33858100019464070002087280000033000000259820000011334000373160000270660002219550000672658000779560006354400001038620001782458000085482000268519800064660009577700034600990005679649000366307000446509500048314020004831402000788000000788000330700055364000386600063325000530580000804000178262000179066000339450007435910003740200031610000768000784922000008482470005679649000Other non-current financial assets11334000Non Current Tax Assets (net)25879000Other non-current assets1187000Other current financial assets85482000Other current assets95777000Other current financial liabilities33945000Other current liabilities3740200021129000239825000-81791000015370200000620000-14244600001373100001155320000-8620000-87060000-771200001209480000-47500000-8210000-330300001726420004922290000007676600004154630000000000072400091915000000000000076880002235900021156000000001063540000-376965000-35291100000000000128596000137386000002112900000-299190003263300003263300071229000103862000Items that will not be reclassified to profit / loss55000005500000Items that will not be reclassified to profit / loss3476000347600013840008750000041160002601000CHEMCON SPECIALITY CHEMICALS LIMITED******Kamalkumar Rajendra Aggarwal******Chairman & Managing DirectorRemuneration-6700000438900028480001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Naresh Vijaykumar Goyal******Joint Managing DirectorRemuneration-4900000449300029480001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Navdeep Naresh Goyal******Whole-time DirectorRemuneration-18000004070001830001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Rajesh Chimanlal Gandhi******Whole-time Director and Chief Financial OfficerRemuneration-24300003030003030001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Himanshu Prafulchandra Purohit******Whole-time DirectorRemuneration-24300003030003030001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Shahilkumar Maheshbhai Kapatel******Company Secretary & Compliance OfficerRemuneration-5930001910001250001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Remuneration does not include provisions made for Gratuity as it is determined on an actuarial basis for the Company as a whole.CHEMCON SPECIALITY CHEMICALS LIMITED******Bharat Chunilal Shah******Independent DirectorAny other transactionDirector Sitting Fees-2500018000140001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable.CHEMCON SPECIALITY CHEMICALS LIMITED******Neelu Atulkumar Shah******Independent DirectorAny other transactionDirector Sitting Fees-20000500001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable.CHEMCON SPECIALITY CHEMICALS LIMITED******Pankaj Amritlal Shah******Independent DirectorAny other transactionDirector Sitting Fees-3000014000140001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable.CHEMCON SPECIALITY CHEMICALS LIMITED******Lalit Ramniklal Mehta******Independent DirectorAny other transactionDirector Sitting Fees-0900001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable.CHEMCON SPECIALITY CHEMICALS LIMITED******Neel Snehalkumar Shah******Independent DirectorAny other transactionDirector Sitting Fees-10000001. Remuneration/Director Sitting Fees was approved by the Board of Directors and/or Shareholders as per Companies Act,2013 and rules thereon. 2. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable.CHEMCON SPECIALITY CHEMICALS LIMITED******Kamalkumar Rajendra Aggarwal******Chairman & Managing DirectorAny other transactionRent expense1200000-9000016000160001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Minal Kamal Aggrawal******Relative of Key Management PersonnelAny other transactionRent expense1200000-9000014000140001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Puja Sarman Shah******Relative of Key Management PersonnelAny other transactionRent expense1200000-9000014000140001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Parul Utssav Gupta******Relative of Key Management PersonnelAny other transactionRent expense1200000-9000014000140001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Super Chemical Industries******Entities over which Key Management Personnel or their Relative have significant influence or ControlSale of goods or services200000000-947800041920004020001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Shivam Petrochem Industries******Entities over which Key Management Personnel or their Relative have significant influence or ControlSale of goods or services200000000-02955700001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with Shivam Petrochem Industries as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Dtech Products Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlSale of goods or services200000000-0673900001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with Dtech Products Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Dtech Products Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of goods or services200000000-3855000015110001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.3.The maximum value of the transactions, in aggregate, which can be allowed with Dtech Products Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Medicap Healthcare Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of goods or services200000000-18422000022640001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with Medicap Healthcare Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Medicap Industries******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of goods or services200000000-29611000185500042700001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Shivam Petrochem Industries******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of goods or services200000000-822700046500001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.3.The maximum value of the transactions, in aggregate, which can be allowed with Shivam Petrochem Industries as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Supertech Fabrics Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of goods or services200000000-1000025000100001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.CHEMCON SPECIALITY CHEMICALS LIMITED******Dtech Products Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlPurchase of fixed assets200000000-3143000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.3.The maximum value of the transactions, in aggregate, which can be allowed with Dtech Products Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Medicap Healthcare Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlAny other transactionReimbursement of expenses Received200000000-2680000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with Medicap Healthcare Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******KASR Healthcare Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlAny other transactionReimbursement of expenses Received200000000-1130000730001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with KASR Healthcare Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******KASR Healthcare Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlSale of goods or services200000000-165000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with KASR Healthcare Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Medicap Healthcare Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlSale of goods or services200000000-1372000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year. 3.The maximum value of the transactions, in aggregate, which can be allowed with Medicap Healthcare Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Shivam Petrochem Industries******Entities over which Key Management Personnel or their Relative have significant influence or ControlAny other transactionPurchase Consideration – Business Acquisition (Going Concern Basis)1000000000-36000000000Through Slump Sale Agreement, the Company acquired the entire business undertaking of M/s. Shivam Petrochem Industries (Partnership Firm, a related party) as a going concern for a lump sum consideration of Rs. 3600 lakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Dtech Products Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlAny other transactionReimbursement of expenses Paid200000000-712000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.3.The maximum value of the transactions, in aggregate, which can be allowed with Dtech Products Private Limited as approved by Audit Committee for one financial year is INR 2000 LakhsCHEMCON SPECIALITY CHEMICALS LIMITED******Dtech Products Private Limited******Entities over which Key Management Personnel or their Relative have significant influence or ControlAny other transactionReimbursement of expenses Received200000000-20000001. Transactions amounts reported are exclusive of GST and closing balances reported are inclusive of GST, wherever applicable. 2. The value of the related party transaction denotes the amount approved by the Audit Committee, as applicable, for one year.3.The maximum value of the transactions, in aggregate, which can be allowed with Dtech Products Private Limited as approved by Audit Committee for one financial year is INR 2000 Lakhs457106000AuditedtrueShah Mehta & Bakshitrue2028-07-31